RBSH 0.01 Rebus Holdings, Inc.
| Range: | 1.0E-4-0.0149 | Vol Avg: | 796 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.1 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Nov 04 2009 | Empoloyees: | 1 | ||
| CUSIP: | 75619J103 | CIK: | 0001421204 | ISIN: | US75619J1034 | Country: | US |
| CEO: | Mr. Raul Silvestre Esq. | Website: | https://www.rebus-corp.com | ||||
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow